GlassScriptPhysician profile
Leonid M Kozer
NPI 1396798872
$3,792.46
in general payments reported to CMS, 2019-2025
24 companies · $397 in 2025
The $397 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $926 · 2020: $539 · 2021: $516 · 2022: $426 · 2023: $431 · 2024: $558 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,376 · Education: $9.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,376.39 |
| Education | $9.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $545.52 | 2019-2025 | |
| Amgen INC. | $460.93 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $367.16 | 2023-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $358.40 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $342.67 | 2022-2025 | Verquvo |
| Boston Scientific Corporation | $324.76 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $279.50 | 2020-2024 | |
| Janssen Pharmaceuticals, INC | $173.93 | 2019-2021 | |
| Pfizer INC. | $167.48 | 2019-2024 | |
| Abbott Laboratories | $123.86 | 2019-2021 | |
| Edwards Lifesciences Corporation | $104.19 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Biotronik INC. | $94.15 | 2020-2025 | Acticor 7 Vr-T Dx |
| Regeneron Healthcare Solutions, INC. | $74.63 | 2019 | |
| Heartflow, INC. | $72.16 | 2025 | |
| Bardy Diagnostics, INC. | $58.40 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $55.54 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $41.21 | 2023-2024 | Farxiga |
| Abiomed | $35.15 | 2025 | |
| Medicomp INC | $24.99 | 2025 | Telepatch Cardiac Monitor |
| Irhythm Technologies, INC. | $23.00 | 2022 | |
| Amarin Pharma, INC. | $20.73 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.78 | 2019 | |
| Medtronic Vascular, INC. | $13.82 | 2020 | |
| Allergan, INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonid Kozer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.